InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Monday, 08/07/2017 9:31:13 PM

Monday, August 07, 2017 9:31:13 PM

Post# of 345964
Current bylaws need some updating for Peregrine

...simply seeing that Medarex BOD did not look and seek competitive offers is crazy and how could a BOD allow such fiduciary duty failures?

Peregrine should learn from this Medarex sale and update their bylaws WITH this year's proxy vote and make sure the Poison Pill is enforced and kept in place


"
Goldman Sachs' Letter to MEDX Board of Directors (BOD) OPENLY Acknowledges that MEDX BOD Failed to Perform Its Fiduciary Responsibilities.... "

" "We [Goldman Sachs] were not requested to solicit, and did not solicit, interest from other parties with respect to an acquisition of or other business combination with the Company."

http://melanomamissionary.blogspot.com/2009/08/is-medarex-and-bristol-meyer-squibb-in.html?m=1

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News